DUBLIN--(BUSINESS WIRE)--The "Software as a Medical Device: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering.
In this report, the market has been segmented based on product type and geography. The report provides an overview of the software as a medical device market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027. Revenue forecasts for this period are segmented based on product type and geography. Market values have been estimated based on the total revenue of SaMD manufacturers and key vendors.
Increasing venture capital funding in SaMD technology, growing demand for SaMD application in accurate diagnosis, disease prevention are some of the key factors driving the growth of the SaMD market.
However, cybersecurity concerns and unsettled regulatory environment across regions such as North America and Europe are hindering market growth.
Apart from drivers and restraints, increasing adoption of SaMD; the advent of artificial intelligence (AI), machine learning (ML) and the Internet of Things (IoT); and a rising number of SaMD start-ups will create huge opportunities for vendors in the market.
In this report, the global SaMD market has been segmented into desktops/laptops, smartphones/tablets and wearable devices.
By geography, the software as a medical device market has been segmented into North America, Europe, Asia-Pacific, and RoW. The North American region is currently the dominant market. The presence of major companies, robust technology infrastructure, surge in demand for digital health and high adoption of advanced technologies, such as AI, IoT and cloud-based healthcare services, are some of the key factors driving the North American market.
Report Includes
- A brief general outlook of the global market for software as a medical device (SaMD)
- Analyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Understanding of the upcoming market opportunities for SaMD products market and digital health solutions, and areas of focus to forecast the market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for software as a medical device market, and corresponding market share analysis by product type and region
- Review of the impact of COVID-19 pandemic on the medical devices market
- Market share analysis of leading medical device manufacturers, their research priorities, technology advancements, and market development strategies
- Company profiles of the leading industry players, including Abbott Laboratories, Arterys, DexCom Inc. and Hyperfine Inc.
Key Topics Covered:
Chapter 1 Market Outlook
1.1 Market Snapshot
Chapter 2 Executive Summary
Chapter 3 Market Definitions and Background
3.1 Overview
3.2 Definitions and Background
3.2.1 Difference Between Medical Device Software and Samd
3.2.2 Samd Utilizing Artificial Intelligence and Machine Learning (Ai/Ml)
3.2.3 Examples of Software That Are Not Software as a Medical Device
3.2.4 Five Applications of Software as a Medical Device
3.3 Regulation of Software as a Medical Device (Samd)
3.3.1 Historic Foundations
3.3.2 Outlook of Regulatory Process in 2021
3.3.3 Future Scenario
3.4 International Samd Regulations
3.4.1 Samd Regulation in the Eu
3.4.2 Samd Regulation in the U.S.
Chapter 4 Market Dynamics
4.1 Market Drivers
4.2 Market Trends
4.3 Market Opportunities
4.4 Market Restraints
Chapter 5 Market Breakdown by Product
5.1 Introduction
5.2 Samd: Desktops/Laptops
5.3 Samd: Smartphone/Tablets
5.4 Samd: Wearable Devices
Chapter 6 Market Breakdown by Region
6.1 Global Software as a Medical Device Market Size by Region
6.1.1 North America
6.1.2 Europe
6.1.3 Asia-Pacific
6.1.4 Rest of the World
Chapter 7 Covid-19 Impact on the Samd Market
7.1 Introduction
7.2 Impact of Covid-19 on Medtech Industry
7.3 Covid-19 Impact on Samd Market
Chapter 8 Competitive Landscape
8.1 Industry Scenario
8.2 Company Shares
8.3 Competitive Analysis
Chapter 9 Company Profiles
Chapter 10 Project Scope and Methodology
10.1 Scope of Report
10.2 Methodology
10.3 Analyst's Credentials
10.4 Related Research Reports
Companies Mentioned
- Abbott Laboratories
- Arterys
- Dexcom Inc.
- Fujifilm Holdings Corp.
- General Electric Co.
- Hyperfine, Inc.
- Icad Inc.
- Koninklijke Philips N.V.
- Medtronic plc
- Mitac International Corp.
- Omega Medical Imaging LLC
- Siemens Healthineers
For more information about this report visit https://www.researchandmarkets.com/r/4ly1oh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
